The path coefficient (β2) from baseline BMI to follow-up insulin was significantly greater in the MetS group than in non-MetS group (0.510 vs 0.190, p < 0.001) and in the hyperglycemic group than normoglycemic group (0.503 vs 0.285, p = 0.026). Here, INS is linked to metabolic syndrome.